Cardiac Surgery in Patients with Opioid Use Disorder: An Analysis of 1.7 Million Surgeries.
Adverse repercussions associated with the current opioid epidemic have been documented in many surgical specialties. The extent of this problem in the cardiac surgery population, however, has not been previously characterized. We evaluated the impact of opioid use disorder (OUD) on in-hospital cardiac surgery outcomes using a large national database. Using the National Inpatient Sample, we isolated patients undergoing coronary artery bypass grafting, valve repair or valve replacement from 2009-2014. Patients were stratified by OUD status. Multivariable analysis was performed to evaluate the association between opioid use and postoperative outcomes. Patients were further stratified by surgery type. Overall, 1,743,161 patients underwent cardiac surgery, and 6,960 patients suffered from OUD (0.4%). Mean age was 47.2 and 65.8 years among those with and without OUD, respectively. Although in-hospital mortality did not differ among these groups, OUD patients had significantly higher incidence of stroke (8.3% vs 2.8%), acute kidney injury (21.4% vs 16.2%), longer hospital stays (18 vs. 10 days) and higher hospitalization costs ($81,238 vs $58,654; all P<0.01). However, after adjusting for patient and hospital-level factors, OUD was only associated with a longer hospital length of stay (2.2 days, 95% CI: 1.19-3.20) compared to non-opioid users. OUD among cardiac surgery patients is associated with prolonged hospitalization and increased risk of postoperative morbidity, and mainly driven by the patient's preoperative risk factors. Strategies to minimize these risk factors at prehospitalization level is warranted to curb the opioid epidemic and improve overall outcomes in this vulnerable population.